-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WQqI3isAYHOJJ3fRlBBXtaNbspvsLsAiqACXIxbKe0UrSHmrLFQy0i6OoXbFkkk3 KPAuWLUtpr1d4LiylP90IQ== 0001209191-05-033815.txt : 20050628 0001209191-05-033815.hdr.sgml : 20050628 20050628214507 ACCESSION NUMBER: 0001209191-05-033815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050509 FILED AS OF DATE: 20050628 DATE AS OF CHANGE: 20050628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: West John CENTRAL INDEX KEY: 0001320337 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 05922501 BUSINESS ADDRESS: BUSINESS PHONE: 510-670-9300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 4 1 bpa10348_bpa1jw.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-05-09 0000913275 Solexa, Inc. SLXA 0001320337 West John C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 1 1 0 0 Chief Executive Officer Employee Stock Option (right to buy) 6.39 2005-05-09 4 A 0 600000 6.39 A 2015-05-09 Common Stock 600000 600000 D This option will vest and become exercisable in forty-eight (48) equal monthly installments over four (4) years, with vesting to commence as of August 9, 2004. In the event of a Change of Control (as defined in his Employment Agreement with the Company), the vesting and exercisability of the option shall be accelerated by two (2) years. In the event the optionholder's employment with the Company is terminated without Cause (as defined in his Employment Agreement with the Company) or the optionholder resigns his employment for Good Reason (as defined in his Employment Agreement), the vesting and exercisability of the option shall be accelerated by one (1) year (except to the extent such options are accelerated in connnection with a Change of Control). /s/ John West 2005-06-28 -----END PRIVACY-ENHANCED MESSAGE-----